tiprankstipranks
China Medical System Holdings Ltd. (DE:2M7C)
FRANKFURT:2M7C
Germany Market
2M7C
China Medical System Holdings
RESEARCH TOOLSreports

China Medical System Holdings (2M7C) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

2M7C Analyst Ratings

Moderate Buy
2Ratings
Moderate Buy
2 Buy
0 Hold
0 Sell
Based on 2 analysts giving stock ratings to
China
Medical System Holdings
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

2M7C Stock 12 Month Forecast

Average Price Target

€2.18
▲(51.36% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for China Medical System Holdings in the last 3 months. The average price target is €2.18 with a high forecast of €2.23 and a low forecast of €2.13. The average price target represents a 51.36% change from the last price of €1.44.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"€0","3":"€3","0.75":"€0.75","1.5":"€1.5","2.25":"€2.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2.2271284,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€2.23</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.1795641000000003,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€2.18</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.1319998,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€2.13</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,0.75,1.5,2.25,3],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.19,1.2697791076923077,1.3495582153846153,1.429337323076923,1.5091164307692306,1.5888955384615384,1.6686746461538462,1.7484537538461538,1.8282328615384613,1.908011969230769,1.9877910769230769,2.067570184615384,2.147349292307692,{"y":2.2271284,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.19,1.2661203153846154,1.3422406307692307,1.4183609461538462,1.4944812615384615,1.570601576923077,1.6467218923076925,1.7228422076923078,1.7989625230769233,1.8750828384615388,1.951203153846154,2.02732346923077,2.103443784615385,{"y":2.1795641000000003,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.19,1.262461523076923,1.3349230461538462,1.4073845692307692,1.4798460923076924,1.5523076153846154,1.6247691384615384,1.6972306615384616,1.7696921846153846,1.8421537076923076,1.9146152307692308,1.9870767538461538,2.059538276923077,{"y":2.1319998,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.101,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.238,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.364,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.452,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.482,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.452,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.472,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.383,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.59,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.501,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.452,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.35,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.19,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€2.23Average Price Target€2.18Lowest Price Target€2.13
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
China Renaissance Analyst forecast on DE:2M7C
Unknown Analyst
China Renaissance
Not Ranked
China Renaissance
€2.23
Buy
54.66%
Upside
Reiterated
06/25/26
China Renaissance Sticks to Their Buy Rating for China Medical System Holdings (CHSYF)
Guotai Haitong Analyst forecast on DE:2M7C
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
€2.08→€2.13
Buy
48.06%
Upside
Reiterated
04/29/26
Guotai Haitong Keeps Their Buy Rating on China Medical System Holdings (CHSYF)
First Shanghai Securities Analyst forecast on DE:2M7C
Unknown Analyst
First Shanghai Securities
Not Ranked
First Shanghai Securities
€2.16
Buy
50.00%
Upside
Reiterated
03/19/26
First Shanghai Securities Sticks to Its Buy Rating for China Medical System Holdings (CHSYF)
CICC Analyst forecast on DE:2M7C
Unknown Analyst
CICC
Not Ranked
CICC
€1.85→€1.96
Buy
36.01%
Upside
Reiterated
03/18/26
CICC Sticks to Their Buy Rating for China Medical System Holdings (CHSYF)
Guoyuan Securities (HK) Analyst forecast on DE:2M7C
Unknown Analyst
Guoyuan Securities (HK)
Not Ranked
Guoyuan Securities (HK)
€1.98
Buy
37.41%
Upside
Reiterated
12/17/25
China Medical System Holdings (CHSYF) Gets a Buy from Guoyuan Securities (HK)
TFI Asset Management Analyst forecast on DE:2M7C
Unknown Analyst
TFI Asset Management
Not Ranked
TFI Asset Management
€2
Buy
38.73%
Upside
Reiterated
11/30/25
TFI Asset Management Remains a Buy on China Medical System Holdings (CHSYF)
Morgan Stanley Analyst forecast on DE:2M7C
Unknown Analyst
Morgan Stanley
Not Ranked
Morgan Stanley
€1.57→€1.68
Hold
16.58%
Upside
Reiterated
10/31/25
China Securities International Analyst forecast on DE:2M7C
Unknown Analyst
China Securities International
Not Ranked
China Securities International
€2.01
Buy
39.58%
Upside
Reiterated
09/07/25
HSBC Analyst forecast on DE:2M7C
Linda Shu
HSBC
HSBC
€1.88
Buy
30.57%
Upside
Reiterated
08/27/25
Citic Securities Analyst forecast on DE:2M7C
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
€2.01
Buy
39.90%
Upside
Reiterated
08/25/25
CLSA Analyst forecast on DE:2M7C
Michael Luo CFA
CLSA
CLSA
€1.12→€1.75
Buy
21.24%
Upside
Reiterated
08/20/25
China Medical System Holdings (CHSYF) Gets a Buy from CLSA
Citi Analyst forecast on DE:2M7C
Unknown Analyst
Citi
Not Ranked
Citi
€1.86
Buy
29.01%
Upside
Reiterated
08/19/25
Goldman Sachs Analyst forecast on DE:2M7C
Ziyi Chen
Goldman Sachs
Goldman Sachs
€2.01
Buy
39.27%
Upside
Reiterated
08/19/25
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
China Renaissance Analyst forecast on DE:2M7C
Unknown Analyst
China Renaissance
Not Ranked
China Renaissance
€2.23
Buy
54.66%
Upside
Reiterated
06/25/26
China Renaissance Sticks to Their Buy Rating for China Medical System Holdings (CHSYF)
Guotai Haitong Analyst forecast on DE:2M7C
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
€2.08→€2.13
Buy
48.06%
Upside
Reiterated
04/29/26
Guotai Haitong Keeps Their Buy Rating on China Medical System Holdings (CHSYF)
First Shanghai Securities Analyst forecast on DE:2M7C
Unknown Analyst
First Shanghai Securities
Not Ranked
First Shanghai Securities
€2.16
Buy
50.00%
Upside
Reiterated
03/19/26
First Shanghai Securities Sticks to Its Buy Rating for China Medical System Holdings (CHSYF)
CICC Analyst forecast on DE:2M7C
Unknown Analyst
CICC
Not Ranked
CICC
€1.85→€1.96
Buy
36.01%
Upside
Reiterated
03/18/26
CICC Sticks to Their Buy Rating for China Medical System Holdings (CHSYF)
Guoyuan Securities (HK) Analyst forecast on DE:2M7C
Unknown Analyst
Guoyuan Securities (HK)
Not Ranked
Guoyuan Securities (HK)
€1.98
Buy
37.41%
Upside
Reiterated
12/17/25
China Medical System Holdings (CHSYF) Gets a Buy from Guoyuan Securities (HK)
TFI Asset Management Analyst forecast on DE:2M7C
Unknown Analyst
TFI Asset Management
Not Ranked
TFI Asset Management
€2
Buy
38.73%
Upside
Reiterated
11/30/25
TFI Asset Management Remains a Buy on China Medical System Holdings (CHSYF)
Morgan Stanley Analyst forecast on DE:2M7C
Unknown Analyst
Morgan Stanley
Not Ranked
Morgan Stanley
€1.57→€1.68
Hold
16.58%
Upside
Reiterated
10/31/25
China Securities International Analyst forecast on DE:2M7C
Unknown Analyst
China Securities International
Not Ranked
China Securities International
€2.01
Buy
39.58%
Upside
Reiterated
09/07/25
HSBC Analyst forecast on DE:2M7C
Linda Shu
HSBC
HSBC
€1.88
Buy
30.57%
Upside
Reiterated
08/27/25
Citic Securities Analyst forecast on DE:2M7C
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
€2.01
Buy
39.90%
Upside
Reiterated
08/25/25
CLSA Analyst forecast on DE:2M7C
Michael Luo CFA
CLSA
CLSA
€1.12→€1.75
Buy
21.24%
Upside
Reiterated
08/20/25
China Medical System Holdings (CHSYF) Gets a Buy from CLSA
Citi Analyst forecast on DE:2M7C
Unknown Analyst
Citi
Not Ranked
Citi
€1.86
Buy
29.01%
Upside
Reiterated
08/19/25
Goldman Sachs Analyst forecast on DE:2M7C
Ziyi Chen
Goldman Sachs
Goldman Sachs
€2.01
Buy
39.27%
Upside
Reiterated
08/19/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering China Medical System Holdings

3 Months
Linda ShuHSBC
Success Rate
3/3 ratings generated profit
100%
Average Return
+18.60%
Copying Linda Shu's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +18.60% per trade.
1 Year
Linda ShuHSBC
Success Rate
3/3 ratings generated profit
100%
Average Return
+25.27%
Copying Linda Shu's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +25.27% per trade.
2 Years
Linda ShuHSBC
Success Rate
2/3 ratings generated profit
67%
Average Return
+17.93%
Copying Linda Shu's trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +17.93% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

2M7C Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
2
4
5
4
2
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
2
4
5
4
2
In the current month, 2M7C has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 2M7C average Analyst price target in the past 3 months is 2.18.
Each month's total comprises the sum of three months' worth of ratings.

2M7C Financial Forecast

2M7C Earnings Forecast

Next quarter’s earnings estimate for 2M7C is €0.05 with a range of €0.05 to €0.05. The previous quarter’s EPS was €0.03. 2M7C beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 2M7C has Performed in-line its overall industry.
Next quarter’s earnings estimate for 2M7C is €0.05 with a range of €0.05 to €0.05. The previous quarter’s EPS was €0.03. 2M7C beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 2M7C has Performed in-line its overall industry.

2M7C Sales Forecast

Next quarter’s sales forecast for 2M7C is €596.91M with a range of €596.91M to €596.91M. The previous quarter’s sales results were €509.87M. 2M7C beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 2M7C has Performed in-line its overall industry.
Next quarter’s sales forecast for 2M7C is €596.91M with a range of €596.91M to €596.91M. The previous quarter’s sales results were €509.87M. 2M7C beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 2M7C has Performed in-line its overall industry.

2M7C Stock Forecast FAQ

What is DE:2M7C’s average 12-month price target, according to analysts?
Based on analyst ratings, China Medical System Holdings Ltd.’s 12-month average price target is 2.18.
    What is DE:2M7C’s upside potential, based on the analysts’ average price target?
    China Medical System Holdings Ltd. has 51.36% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is China Medical System Holdings Ltd. a Buy, Sell or Hold?
          China Medical System Holdings Ltd. has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
            What is China Medical System Holdings Ltd.’s share price target?
            The average share price target for China Medical System Holdings Ltd. is 2.18. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €2.23 ,and the lowest forecast is €2.13. The average share price target represents 51.36% Increase from the current price of €1.44.
              What do analysts say about China Medical System Holdings Ltd.?
              China Medical System Holdings Ltd.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
                How can I buy shares of China Medical System Holdings Ltd.?
                To buy shares of DE:2M7C, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.